Updated:
NANOMIX Corp
NANOMIX Corp is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001473579, and its reported industry is...
Overview
NANOMIX Corp is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001473579, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2023-04-07, it reported annual revenue of USD 15,450; total assets of USD 982,055 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- NANOMIX Corp
- Former names in filing history
- Boston Therapeutics, Inc. (2010-03-08 to 2021-11-05); AVANYX Therapeutics, Inc. (2010-02-08 to 2010-11-23)
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Lawrence, MA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001473579
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2022USD | $15,450 | — | $982,055 | — | -$6.1M | |
| FY2021USD | $141,778 | — | $905,712 | $297,351 | -$6.3M | |
| FY2020USD | $9,336 | -$907,883 | $19,900 | $7,402 | -$784,299 | |
| FY2019USD | $16,329 | -$3.7M | $23,781 | $6,701 | -$1.2M |
FY2020. Revenue, Total assets, Cash and equivalents, Operating cash flow: shown as originally filed; later filings report different values for the same periods.
FY2019. Cash and equivalents: shown as originally filed; later filings report different values for the same periods.
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | CURRENT REPORT | ||
| 10-K | ANNUAL REPORT | ||
| 8-K | FORM 8-K | ||
| 8-K | CURRENT REPORT | ||
| 10-Q | QUARTERLY REPORT | ||
| 8-K | CURRENT REPORT | ||
| 8-K | CURRENT REPORT | ||
| 10-Q | QUARTERLY REPORT | ||
| 8-K | CURRENT REPORT | ||
| S-1 | — | REGISTRATION STATEMENT | |
| 10-Q | QUARTERLY REPORT | ||
| 8-K | CURRENT REPORT |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research NANOMIX Corp in Altss
Track this company’s investors, transactions and relationships in Altss.